• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRAF 外显子 15 和 KRAS 密码子 12、13 突变分析在摩洛哥结直肠癌患者中的研究。

Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.

机构信息

Laboratoire de Biologie des Cancers, Equipe Micro-organismes et Facteurs Oncogènes, Faculté de Médecine et de Pharmacie, Fez, Morocco.

出版信息

Int J Biol Markers. 2010 Oct-Dec;25(4):179-84.

PMID:21161938
Abstract

BACKGROUND

The RAS/RAF/MEK/MAP kinase cascade transduces signals from the cell surface to the nucleus in order to control cellular responses including proliferation, differentiation and survival. We investigated the occurrence of BRAF exon 15 and KRAS codon 12 and 13 mutations in Moroccan patients with colorectal cancer.

METHODS

Sixty-two samples from patients with sporadic colorectal adenocarcinomas were studied for BRAF exon 15 and KRAS codon 12 and 13 mutations. DNA from paraffin-embedded tissue specimens was analyzed by a combination of polymerase chain reaction-high resolution melting and direct sequencing.

RESULTS

Of the analyzed specimens, 29% exhibited KRAS codon 12 or 13 mutations and only 1.6% carried a BRAF codon 600 mutation. KRAS mutations were more often observed in women (35.5%) than in men (22.6%). Patients in the age range between 41 and 60 years were more likely to be carriers of this mutation. No KRAS mutations were detected in patients aged >60 years.

CONCLUSION

Despite the limited study sample, our data suggest that KRAS mutations arise more frequently than BRAF mutations in Moroccan patients with colorectal carcinomas. The KRAS mutation status must be assessed in a large cohort of Moroccan patients to confirm these findings and to determine whether this mutation in combination with extrinsic, environmental or microenvironmental factors might be involved in the high frequency of colorectal cancer in middle-aged Moroccans.

摘要

背景

RAS/RAF/MEK/MAP 激酶级联从细胞表面向细胞核传递信号,以控制包括增殖、分化和存活在内的细胞反应。我们研究了 BRAF 外显子 15 和 KRAS 密码子 12 和 13 突变在摩洛哥结直肠癌患者中的发生情况。

方法

对 62 例散发性结直肠腺癌患者的样本进行了 BRAF 外显子 15 和 KRAS 密码子 12 和 13 突变分析。通过聚合酶链反应-高分辨率熔解和直接测序相结合的方法分析石蜡包埋组织标本中的 DNA。

结果

在所分析的标本中,29%表现出 KRAS 密码子 12 或 13 突变,只有 1.6%携带 BRAF 密码子 600 突变。女性(35.5%)比男性(22.6%)更易发生 KRAS 突变。41 至 60 岁的患者更有可能携带这种突变。在年龄>60 岁的患者中未检测到 KRAS 突变。

结论

尽管研究样本有限,但我们的数据表明,摩洛哥结直肠癌患者中 KRAS 突变的发生率高于 BRAF 突变。必须在大量摩洛哥患者中评估 KRAS 突变状态,以证实这些发现,并确定这种突变是否与外在的、环境或微环境因素相结合,可能参与了摩洛哥中年人群中结直肠癌的高发。

相似文献

1
Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.BRAF 外显子 15 和 KRAS 密码子 12、13 突变分析在摩洛哥结直肠癌患者中的研究。
Int J Biol Markers. 2010 Oct-Dec;25(4):179-84.
2
[Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].实时定量PCR-桑格测序法与TaqMan探针法检测结直肠癌KRAS/BRAF突变的比较分析
Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):77-82.
3
[Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].[结直肠癌中KRAS、BRAF、PIK3CA和EGFR基因突变的检测]
Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):590-4. doi: 10.3760/cma.j.issn.0529-5807.2012.09.004.
4
Highly conserved sequence of exon 15 BRAF gene and KRAS codon 12 mutation among Greek patients with colorectal cancer.希腊结直肠癌患者中BRAF基因第15外显子的高度保守序列及KRAS密码子12突变
Int J Biol Markers. 2007 Jan-Mar;22(1):12-8. doi: 10.1177/172460080702200102.
5
Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.KRAS和BRAF中的伴随突变及剪接变体表明晚期结直肠癌中Ras/Raf信号通路存在复杂的扰动。
Gut. 2009 Sep;58(9):1234-41. doi: 10.1136/gut.2008.159137. Epub 2009 May 26.
6
Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.前列腺腺癌病例中KRAS、BRAF和EGFR基因的分子特征;报告生物信息学描述和复发性突变
Clin Lab. 2015;61(7):749-59. doi: 10.7754/clin.lab.2014.141210.
7
[Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].[中国结直肠癌患者KRAS和BRAF基因的突变:966例病例分析]
Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):579-83. doi: 10.3760/cma.j.issn.0529-5807.2012.09.002.
8
KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer.KRAS、BRAF 和 PIK3CA 基因突变与人类结直肠癌:与转移性结直肠癌的关系。
Oncol Rep. 2011 Jun;25(6):1691-7. doi: 10.3892/or.2011.1217. Epub 2011 Mar 17.
9
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer.KRAS 外显子 2 野生型转移性结直肠癌中 KRAS、BRAF 和 PIK3CA 的高分辨率熔解分析。
BMC Cancer. 2013 Apr 1;13:169. doi: 10.1186/1471-2407-13-169.
10
The proto-oncogene KRAS and BRAF profiles and some clinical characteristics in colorectal cancer in the Turkish population.土耳其人群结直肠癌中原癌基因KRAS和BRAF概况及一些临床特征
Genet Test Mol Biomarkers. 2013 Feb;17(2):135-9. doi: 10.1089/gtmb.2012.0290. Epub 2013 Jan 8.

引用本文的文献

1
Diagnostic accuracy of high-resolution melting curve analysis for discrimination of oncology-associated mutations: a systematic review and meta-analysis.高分辨率熔解曲线分析鉴别肿瘤相关突变的诊断准确性:一项系统评价和荟萃分析
J Int Med Res. 2025 Feb;53(2):3000605241311133. doi: 10.1177/03000605241311133.
2
Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review.通路突变作为中东地区结直肠癌的预测性生物标志物:一项系统评价
Clin Med Insights Oncol. 2024 May 25;18:11795549241255651. doi: 10.1177/11795549241255651. eCollection 2024.
3
Correlation between KRAS and NRAS mutational status and clinicopathological features in 414 cases of metastatic colorectal cancer in Morocco: the largest North African case series.
摩洛哥 414 例转移性结直肠癌 KRAS 和 NRAS 突变状态与临床病理特征的相关性:最大的北非病例系列。
BMC Gastroenterol. 2023 Jun 5;23(1):193. doi: 10.1186/s12876-023-02694-7.
4
Clinical Significance of Somatic Mutations in RAS/RAF/MAPK Signaling Pathway in Moroccan and North African Colorectal Cancer Patients.摩洛哥和北非结直肠癌患者 RAS/RAF/MAPK 信号通路中体细胞突变的临床意义。
Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3725-3733. doi: 10.31557/APJCP.2022.23.11.3725.
5
Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa.北非结直肠癌中 RAS/RAF/MEK/ERK/MAPK 信号通路突变的流行率和模式。
BMC Cancer. 2022 Nov 7;22(1):1142. doi: 10.1186/s12885-022-10235-w.
6
Dietary Fat Intake and Mutations in Colorectal Cancer in a Moroccan Population.饮食脂肪摄入量与摩洛哥人群结直肠癌中的突变。
Nutrients. 2022 Jan 13;14(2):318. doi: 10.3390/nu14020318.
7
A Review of Cancer Genetics and Genomics Studies in Africa.非洲癌症遗传学与基因组学研究综述
Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400. eCollection 2020.
8
K-ras Mutation in Colorectal Cancer, A Report from Southern Iran.伊朗南部结直肠癌中K-ras基因突变报告
Iran J Med Sci. 2015 Sep;40(5):454-60.
9
Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.表观遗传学可以解释一些摩洛哥人群结直肠癌的特点:微卫星不稳定性途径探索。
Diagn Pathol. 2015 Jun 24;10:77. doi: 10.1186/s13000-015-0326-9.
10
Diagnostic accuracy of high resolution melting analysis for detection of KRAS mutations: a systematic review and meta-analysis.高分辨率熔解分析检测KRAS突变的诊断准确性:一项系统评价和荟萃分析
Sci Rep. 2014 Dec 17;4:7521. doi: 10.1038/srep07521.